Abstract
The myotonolytic activity of a new muscle-relaxant, DS 103-282, was compared with that of diazepam in a randomized double-blind study on thirty patients suffering from acute muscular spasm due to disorders of the cervical and lumbar segments of the spine. Fifteen patients received 4 mg DS 103-282 and fifteen received 5 mg diazepam on a three times daily regime for 7 days.
DS 103-282 was found to alleviate symptoms and improve mobility to a significant degree (p ≥ 0.05) in all parameters evaluated and was also significantly superior to diazepam in 5 of these. Onset of action was particularly rapid for DS 103-282. Both medications were well tolerated and there was no significant difference between them.
On the basis of these data DS 103-282 may be considered a more powerful and faster-acting myotonolytic agent than diazepam with which it was compared in similar clinical indications.
Get full access to this article
View all access options for this article.